Mirion to Present at Citi's 2026 Global Industrial Tech and Mobility Conference

Mirion Technologies, Inc. (NYSE: MIR) has announced that its Chairman and CEO, Thomas Logan, along with CFO and Medical Group President, Brian Schopfer, will participate in Citi's 2026 Global Industrial Tech and Mobility Conference. Their presentation is scheduled for 2:40 PM ET on February 18, 2026. Investors and interested parties can access a live webcast of the presentation through Mirion's Investor Relations Page, where an archivable link will also be available for future viewing.

Mirion is recognized as a global frontrunner in radiation safety, science, and medicine. With a significant focus on providing advanced solutions that harness the potential of ionizing radiation, Mirion caters to various crucial sectors. Its Nuclear & Safety group offers state-of-the-art radiation safety technologies that are essential for operations in research and development laboratories, nuclear facilities, and frontline applications. Concurrently, the Mirion Medical group focuses on enhancing safety and efficiency within healthcare, delivering solutions that support nuclear medicine, radiation therapy quality assurance, occupational dosimetry, and diagnostic imaging.

Headquartered in Atlanta, Georgia, Mirion employs approximately 3,200 individuals and has a presence in 12 countries, underscoring its global reach and expertise in radiation safety. The company's dedication to innovation is enabling it to deliver vital protection across diverse end markets, making it a key player in its field. For further details about the company and its offerings, stakeholders are encouraged to visit their official website at mirion.com.

For investor inquiries, Eric Linn can be contacted via email at ir@mirion.com, while media inquiries should be directed to Erin Schesny at media@mirion.com.

As Mirion Technologies (NYSE: MIR) prepares for its presentation at the Citi 2026 Global Industrial Tech and Mobility Conference, investors should closely monitor key elements that may impact the company's future performance. Chairman and CEO Thomas Logan, alongside CFO Brian Schopfer, will likely highlight Mirion's robust position in radiation safety and its strategic initiatives to enhance innovation within various growth sectors.

Given Mirion's dual focus on Nuclear & Safety technologies and Medical solutions, it stands to benefit from ongoing expansion in healthcare and nuclear safety regulations, particularly as concerns around nuclear energy and medical diagnostics intensify globally. The company's commitment to R&D may serve as a catalyst for new product developments and enhance its competitive edge.

In preparation for the conference, investors should assess Mirion's recent financial performance, including revenue growth rates and profitability metrics, to gauge its fiscal health. Pay attention to metrics related to segments driving growth, particularly in medical technologies related to radiation therapy and occupational safety—a sector that is increasingly vital as healthcare systems modernize and focus on patient safety.

Market dynamics, including legislative changes toward safer energy solutions and increased global healthcare spending, should also be on investors' radar. If Mirion successfully articulates its growth strategy and reinforces its market leadership during the presentation, it could generate positive sentiment and upward movement in its stock price.

As always, investors might want to consider potential risks, including competition in the radiation safety sector and regulatory hurdles. Monitoring the subsequent analysis and reports following the presentation will also provide additional insights into Mirion’s strategic direction and future performance. In summary, Mirion presents a compelling investment opportunity, contingent upon effective execution of its strategies and timely market responsiveness.